TRUP

Trupanion

Stock NASDAQ – Stock Market Prices, News & Analysis

Trupanion Inc provides pet insurance, covering healthcare costs related to illness and accidents.

$ 25.45
0.22 %

Trupanion

$ 25.45
0.22 %
TRUP

Trupanion Inc provides pet insurance, covering healthcare costs related to illness and accidents.

Price history of Trupanion
Price history of Trupanion

Performance & Momentum

6 Months 39.85 %
1 Year 26.14 %
3 Years 39.93 %
5 Years 66.35 %

Strategic Analysis

Trupanion • 2026

Trupanion Inc positions itself as a specialized player in pet health insurance, focused on a renewable subscription model. Its differentiation lies in the extensive coverage of costs related to illnesses and accidents, targeting a growing market supported by increasing veterinary expenses.

Strengths
  • Recurring subscription model providing visibility on medium-term revenues
  • Achievement of a significant annual revenue threshold exceeding $1 billion
  • Prospect of returning to profitability in 2025, bolstering investor confidence
Weaknesses
  • Recent volatility with disappointing quarterly results negatively impacting the stock price
  • Declining stock performance in the medium and long term, reflecting operational or market challenges
Momentum

The stock's momentum remains fragile despite a significant milestone reached in terms of revenue and the prospect of upcoming profitability. The mixed results from the last quarter led to a price correction, highlighting a high sensitivity to financial announcements. In the medium term, the market’s reaction indicates a need for confirmation of operational and financial progress before a sustainable recovery.

Analysis performed 1 month ago

Similar stocks to Trupanion

Recent News

Trupanion

illustration
Trupanion Q4 2025 Mixed Results Send Shares Down
1 month ago

Trupanion (NASDAQ: TRUP) reported mixed Q4 2025 financial results. Revenue rose 11.7% to $376.9 million, beating Wall Street expectations. However, earnings per share (EPS) disappointed at $0.13, 20.1% below consensus. Shares fell 8.5% in morning trading following the announcement. Despite record revenue growth and ambitious plans for 2026, investors remain cautious amid margin pressures and shifts in the pet insurance market.

Was this page helpful?

Your feedback helps us improve our research.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases
Anantys Invest on iPhone